Baystate Wealth Management »

Candel Therapeutics shares owned by Baystate Wealth Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Baystate Wealth Management from 13F filings

Historical chart of Baystate Wealth Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Baystate Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Baystate Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $113k 77k 1.47
2023-09-30 $90k 97k 0.92
2023-06-30 $127k 101k 1.26
2023-03-31 $143k 106k 1.35

More positions owned by Baystate Wealth Management

Ishares Russell Top 200 Growth Etf Etf (IWY)
Spdr S&p World Ex-us Etf (SPDW)
Invesco Ftse Rafi Us 1000 Etf Etf (PRF)
Ishares S&p 500 Index Etf (IVV)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Value Etf Etf (VTV)
Invesco Russell 1000 Dynamic Multifactor Etf Etf (OMFL)
Blackrock Ultra Short-term Bond Etf Etf (ICSH)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Tr Russell Midcap Index Etf (IWR)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard S&p Small-cap 600 Etf Etf (VIOO)
Spdr Barclays Capital Short Term Corp Bd Etf (SPSB)
Vanguard Total Bond Market Etf Etf (BND)
Ishares Msci Usa Value Factor Etf Etf (VLUE)

View all positions for Baystate Wealth Management

Top funds holding Candel Therapeutics

Northpond Ventures
Sands Capital Ventures
Vanguard Group
Geode Capital Management
Bridgeway Capital Management
Baystate Wealth Management
BlackRock
Mariner Wealth Advisors
Resources Investment Advisors
Northern Trust
Commonwealth Equity Services
Two Sigma Investments
Tower Research Capital
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Candel Therapeutics